CR20230211A - Derivados de ciclopentatiofen carboxamida como antagonistas del receptor del factor de activación de plaquetas - Google Patents

Derivados de ciclopentatiofen carboxamida como antagonistas del receptor del factor de activación de plaquetas

Info

Publication number
CR20230211A
CR20230211A CR20230211A CR20230211A CR20230211A CR 20230211 A CR20230211 A CR 20230211A CR 20230211 A CR20230211 A CR 20230211A CR 20230211 A CR20230211 A CR 20230211A CR 20230211 A CR20230211 A CR 20230211A
Authority
CR
Costa Rica
Prior art keywords
sup
cyclopentathiophen
antagonists
factor receptor
platelet activation
Prior art date
Application number
CR20230211A
Other languages
English (en)
Inventor
Dieter Wiedenmayer
Marina Kristina Willwacher
Christofer Siegfried Tautermann
Ferenc Kontes
Matthias Eckhardt
Leo Thomas
Juergen Prestle
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of CR20230211A publication Critical patent/CR20230211A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Ciclopentatiofen carboxamidas de la Fórmula (I.0)en donde R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup> y n son como se definen en la descripción y las reivindicaciones, y las sales de este aceptables desde el punto de vista farmacéutico pueden usarse en métodos para el tratamiento de enfermedades que pueden estar influenciadas por antagonizar la actividad mediada por el receptor del factor de activación de plaquetas. <img alt="" src="data:image/png;base64,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 (***)
CR20230211A 2020-11-16 2021-11-12 Derivados de ciclopentatiofen carboxamida como antagonistas del receptor del factor de activación de plaquetas CR20230211A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20207719 2020-11-16
PCT/EP2021/081459 WO2022101377A1 (en) 2020-11-16 2021-11-12 Cyclopentathiophene carboxamide derivatives as platelet activating factor receptor antagonists

Publications (1)

Publication Number Publication Date
CR20230211A true CR20230211A (es) 2023-07-13

Family

ID=73543025

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20230211A CR20230211A (es) 2020-11-16 2021-11-12 Derivados de ciclopentatiofen carboxamida como antagonistas del receptor del factor de activación de plaquetas

Country Status (19)

Country Link
US (2) US11766443B2 (es)
EP (1) EP4244229A1 (es)
JP (2) JP7465368B2 (es)
KR (1) KR20230109692A (es)
CN (2) CN117624188A (es)
AR (1) AR124070A1 (es)
AU (1) AU2021379248A1 (es)
CA (1) CA3200710A1 (es)
CL (2) CL2023001361A1 (es)
CO (1) CO2023005894A2 (es)
CR (1) CR20230211A (es)
DO (1) DOP2023000090A (es)
EC (1) ECSP23036210A (es)
IL (1) IL302769A (es)
JO (1) JOP20230107A1 (es)
MX (1) MX2023005678A (es)
PE (1) PE20231855A1 (es)
SA (1) SA523440809B1 (es)
WO (1) WO2022101377A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119842821A (zh) * 2025-01-06 2025-04-18 华中科技大学 稳定表达血小板活化因子受体的细胞株、构建方法及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3502392A1 (de) 1985-01-25 1986-07-31 Boehringer Ingelheim KG, 6507 Ingelheim Neue thieno-triazolo-1,4-diazepino-2- carbonsaeureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen
JPS62181282A (ja) * 1986-01-21 1987-08-08 ベ−リンガ−　インゲルハイム　コマンデイツト　ゲゼルシヤフト チエノ−１，４−ジアゼピン
PH30676A (en) 1986-07-22 1997-09-16 Boehringer Ingelhein Kg Hetrazepine compounds which have useful pharmaceutical utility
MC1999A1 (fr) * 1987-12-18 1990-01-26 Hoffmann La Roche Composes tricycliques
US4959361A (en) * 1987-12-18 1990-09-25 Hoffmann-La Roche Inc. Triazolo(4,3-A)(1,4)benzodiazepines and thieno (3,2-F)(1,2,4)triazolo(4,3-A)(1,4)diazepine compounds which have useful activity as platelet activating factor (PAF) antagonists
DE3909012A1 (de) 1989-03-18 1990-09-20 Boehringer Ingelheim Kg Verbessertes verfahren zur herstellung von enantiomerenreinen hetrazepinen
DE4010528A1 (de) 1990-04-02 1991-10-17 Boehringer Ingelheim Kg Praeparativ chromatographisches trennverfahren zur herstellung enantiomerenreiner hetrazepine
DE4132763A1 (de) 1991-10-02 1993-04-08 Boehringer Ingelheim Kg Verbessertes verfahren zur herstellung von enantiomerenreinen saeureamiden hetrazepinoider struktur
FR2779652B1 (fr) 1998-06-15 2001-06-08 Sod Conseils Rech Applic Utilisation de diazepines pour la preparation de medicaments destines a traiter les etats pathologiques ou les maladies dans lesquels un des recepteurs de la somatostatine est implique
US20050032713A1 (en) * 2002-03-27 2005-02-10 Wurtman Richard J. Platelet-activating factor antagonists as analgesic, anti-inflammatory, uterine contraction inhibiting, and anti-tumor agents
CA2670031A1 (en) 2006-11-20 2008-05-29 Alantos Pharmaceuticals Holding, Inc. Heterobicyclic metalloprotease inhibitors

Also Published As

Publication number Publication date
DOP2023000090A (es) 2023-06-15
JP7810743B2 (ja) 2026-02-03
JP2024099528A (ja) 2024-07-25
US11766443B2 (en) 2023-09-26
US20220160725A1 (en) 2022-05-26
AR124070A1 (es) 2023-02-08
ECSP23036210A (es) 2023-06-30
JP2023521200A (ja) 2023-05-23
PE20231855A1 (es) 2023-11-21
CN117624188A (zh) 2024-03-01
JOP20230107A1 (ar) 2023-05-16
EP4244229A1 (en) 2023-09-20
US20230355638A1 (en) 2023-11-09
CL2024000317A1 (es) 2024-07-12
JP7465368B2 (ja) 2024-04-10
KR20230109692A (ko) 2023-07-20
MX2023005678A (es) 2023-05-26
IL302769A (en) 2023-07-01
CA3200710A1 (en) 2022-05-19
CO2023005894A2 (es) 2023-05-29
WO2022101377A1 (en) 2022-05-19
CL2023001361A1 (es) 2023-11-03
SA523440809B1 (ar) 2024-10-08
TW202237620A (zh) 2022-10-01
CN116745300A (zh) 2023-09-12
AU2021379248A1 (en) 2023-06-22
AU2021379248A9 (en) 2024-10-10

Similar Documents

Publication Publication Date Title
Feil Weber et al. CARE TRANSITION FROM HOSPITAL TO HOME: INTEGRATIVE REVIEW.
Corcoran et al. NMDA receptors in retrosplenial cortex are necessary for retrieval of recent and remote context fear memory
AR085219A1 (es) 6-cicloalquil-pirazolopirimidinonas para el tratamiento de trastornos del snc
AR113890A1 (es) Preparado farmacéutico con excelentes propiedades de estabilidad a la luz y disolución
UY30267A1 (es) Nuevos derivados de la tioxantina , composiciones farmacéuticas que los contienen, procedimientos de preparacion y aplicaciones
CR20230211A (es) Derivados de ciclopentatiofen carboxamida como antagonistas del receptor del factor de activación de plaquetas
CY1122760T1 (el) Τροποποιητης εξενατιδης και χρηση αυτου
CL2019002601A1 (es) Derivados pirazol[1,5-a]pirimidina sustituidos con alicíclicos farmacológicamente activos.
Elovic et al. The use of atypical antipsychotics after traumatic brain injury
McClellan et al. The use of perioperative antithrombotics in posterior segment ocular surgery
Meyer et al. A note on Thomas Willis' views on the corpus striatum and the internal capsule
Rajkumar Supersensitivity psychosis and its response to asenapine in a patient with delusional disorder
Cammarata-Scalisi et al. Hallazgos clínicos y genéticos de dos casos con síndrome de Apert
Friedman Analogies
Sararoodi et al. The Relationship of History of Hypertension and Illness Cognitive Representation in Post-Myocardial Infarction.
Efird UAB Faculty Development Grant Program awards nearly $100,000 to School of Medicine faculty
Johnson et al. Unique genomic features in adolescent and young adult, as compared to older adult, non-Hodgkin lymphoma and potential therapeutic targets.
CN108784966A (zh) 可移动方便取物和康复两用装置
Gill et al. Ensuring universal access to insulin--the International Insulin Foundation position statement.
Xu et al. In vitro interactions between R207910 and second-line anti-TB drugs or BTZ043 against Mycobacterium tuberculosis by microplate alamar blue assay
Rosenbaum et al. Serotonin syndrome with propofol and remifentanil: mechanistic concern and alternative diagnosis
Nafrialdi Twenty two years of the Medical Journal of Indonesia
Patiño-Toscano Pain management in open nephrectomy
Arbore Control of IFN-γ response via autocrine activation of the C5a complement receptors and the NLRP3 inflammasome within human T lymphocytes
Tatar et al. Clozapine--Induced Neuroleptic Malignant Syndrome Associated with Rapid Dose Escalation.